More Related Content

Multifunctional Graphene enhances targeted cancer therapy.pptx

  1. RATIONAL CHEMICAL MULTIFUNCTIONALIZATION OF GRAPHENE INTERFACE ENHANCES TARGETED CANCER THERAPY M.A LUCHERELLI, G.REINA, A.BIANCO, Y.YU, E.MIYAKO, G.ABELLÀN PRESENTED BY– SHIVIKA MSC (USHS) CHEMISTRY SEM 4 27802109319 ANGEW.CHEM. PUBLISHED IN 2020
  2. CANCER :  Cancer specifically refers to new growth which has ability to spread to sorrounding tissues which may eventually lead to death.  Cancer is the leading cause of death worldwide, accounting for nearly 10 millions of death in 2020.  The most common cancers are breast, lung, colon and rectum or prostate cancer.  It can be cured if detected early and treated effectively.
  3. TRADITIONAL WAYS TO TREATING CANCER : CHEMOTHERAPY:  Use of anti-cancer drugs to destroy cancer cells.  Works by disrupting the growth of cancer cells. RADIATION THERAPY: Use in 2 different ways:  To cure cancer by destroying tumors.  To reduce symptoms by reducing size of a tumor.
  4. NANOTECHNOLOGY:  Nanotechnology is rapidly evolving domain.  In the last decades, The interest on the applications of nanomaterials in Nano medicine has increased Rapidly.  Large varieties of reactions and their properties like specific cell targeting , controlled drug release, photothermal and photodynamic therapies and imaging. Targeted drug delivery approach minimize drug- originated systemic toxic effects.  A great advantage is their ability to complex a high quantity of hydrophobic drugs and improving the uptake and release of drug and improving the selectivity of free drug.  Properties like biocompatibility, amount of drug loading, interaction with biological environment and the biodistribution into the body after administration.
  5. GRAPHENE :  Graphene is an allotrope of carbon consisting of a sheet of 2D single layer sp2 hybridized C atoms.  Each C atom is attached to it’s 3 nearest neighbors C atoms in same plane. Thinnest known material.  Graphene has been found to have good biocompatibility and biodegradability.  Moreover, it’s high surface/mass ratio allows a high drug loading , by absorbing organic molecule through π-π stacking.  Due to easy functionalization and good water dispersibility , GO has been widely studied as drug carrier .  But graphene presents a higher chemical stability wrt GO to reductive conditions and fewer interaction with cell membranes.
  6. MULTIFUNCTIONAL GRAPHENE PLATFORM (MFG):  Covalent multifunctional Graphene platform (mfG).  Focus on targeting , tracking , delivery and photothermal activity of mfg on cancer cells .  We selected ICG as fluorophore , FA as targeting agent , DOX as therapeutic molecule.  The starting material to prepare this Platform corresponds to a multifunctional Graphene which is obtained by Covalent multifunctionalization of KC8 with diazonium salts
  7. BOC : 3° butyloxycarbonyl CBZ : benzyloxycarbonyl Indocyanine green : ICG PHT : Pthalamide MOLECULAR STRUCTURES : Doxorubicin : DOX
  8. SYNTHESIS OF NEW TARGETED DRUG DELIVERY CONJUGATE :  The order of introduction of new functionalities is crucial.  The chemical stability of each functional group under the deprotection conditions of each amine are initially investigated.  The PEG(Polyethylene glycol) Chain plays 2 important roles : 1) To Increase water dispersibility and biocompatibility and 2) To act as a spacer for linking FA to conjugate.  The characteristics of imine bond is its reversibility in acidic medium , at PH<5.5.  The low rxn yield due to steric hindrance caused by PEG chain and the other functionalities on the Surface of graphene.
  9. THERAPEUTIC POTENTIAL :  Water – soluble tetrazolium (WST) – based assay.  48 hr of incubation at increasing doses – a slight cell mortality was observed for Hela cells.  2 factors : low water dispersibility and low amount of DOX .  SOLUTION : we sonicated the prepared mfG/PEG- FA/ICG/DOX in a BSA and Dox Solution.  Drug release efficiency in neutral and acidic conditions.  Evaluated again the in vitro performance.  Selective anti-cancer activity mediated by folate receptor – directed targeting effect.
  10. DOX- COMPLEXED AND FOLIC ACID –FUNCTIONALIZED-MFG GRAPHENE NANOSHEETS COULD BE USED AS AN EFFECTIVE NANOCARRIER FOR SELECTIVE CANCER KILLING.
  11. CELLULAR UPTAKE BEHAVIOUR OF mfg NANO CONJUGATES :  Hela cells were incubated with ICG labelled mfG for 4h and then subjected to live imaging after washing with PBS. The fluorescence signal Of mfG/PEG-FA/ICG was clearly observed.  Fluorescent image merged with DIC images revealed that mfG Nano conjugates were accumulated Into the cytoplasm .  The release of doxorubicin by using confocal fluorescence microscopy. We observe the release of Dox after 4h from incubation .  PBS – Phosphate-buffered saline used in biological research. (PH ~ 7.4)
  12. PHOTOTHERMAL PROPERTIES OF GRAPHENE :  The heating of nanomaterials under NIR enhances the activity of Dox at high temperature.  Hela cells were incubated with BSA, ICG and mfG/PEG- FA/ICG/Dox for 4h and then have been irradiated for 10 min using a 785 nm NIR laser at 1W.  The viability of the cells was measured at 0 and 24h of post- irradiation .  Significant reduction of viability observed after 24 h likely to be attributed to the synergistic effect of heat induced by laser irradiation and a fast Dox release from mfG.  Result : mfG/PEG-FA/ICG/Dox has potential to be used for multimodal therapy (chemo- and phototherapy).
  13. BIOSAFETY OF mfG NANOSHEETS : In vitro toxicity:  Incubated Hela cells with a wide range of concentration of mfG. Results revealed that mfG did not affect cell viability even up to the Concentration of Approx. 150 microgram per ml indicating it is safe for biomedical use . In vivo toxicity:  Examined by key blood parameters. Mice were intravenously injected 100 microlitre of the starting mfG. The hematological and biochemical parameters did not differ underscoring the biosafety of mfG.
  14. CONCLUSION :  Designed and synthesized a multifunctional Graphene-based platform for cancer therapy application.  We demonstrate combined chemo- and photothermal properties of the mfG as drug delivery carrier.  Targeting ability of folic acid for Hela cells.  The in vitro and in vivo toxicity of starting material.  Good cancer killing activity shown by composite Functionalized with doxorubicin.  Internalization was confirmed by live microscopy exploiting ICG as fluorophore.  Combined affect of photo and chemotherapy after NIR irradiation.
  15. THANK YOU